Article

Bravizine: A β-Arrestin–Biased Partial Agonist Targeting Dopamine D2 Receptor Hypersensitivity in Tardive Dyskinesia

2025-11-04

Abstract excerpt

<title>Abstract</title> <p> Tardive dyskinesia (TD) arises from chronic dopamine D2 receptor (D2R) blockade, leading to receptor hypersensitization and maladaptive downstream signaling. To address this, we designed Bravizine, a novel β -arrestin–biased partial agonist, using an AI-augmented ligand optimization workflow built on REINVENT 4 with custom scoring functions for receptor bias prediction, docking affini...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a3b7f7a2-0905-5e29-84f8-f8365aba5b15
DOI: 10.21203/rs.3.rs-8000972/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Bravizine: A β-Arrestin–Biased Partial Agonist Targeting Dopamine D2 Receptor Hypersensitivity in Tardive DyskinesiaDOI 10.21203/rs.3.rs-8000972/v1Read

Bravizine: A β-Arrestin–Biased Partial Agonist Targeting Dopamine D2 Receptor Hypersensitivity in Tardive DyskinesiaSemantic proximity Read

A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.Semantic proximity Read

Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor.Semantic proximity Read

Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs.Semantic proximity Read

A small molecule enhances arrestin-3 binding to the β <sub>2</sub> -adrenergic receptorSemantic proximity Read

BravizineDSE: A Multi-Input Deep Transformer for Receptor-Context-Aware GPCR Signaling Bias Prediction and Derivation of a Six-Feature Molecular Selectivity RuleSemantic proximity Read

Discovery of Selective Small-Molecule Ligands of SV2C by AI-Enhanced Virtual Screening and Experimental ValidationSemantic proximity Read

Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptorSemantic proximity Read

β-Arrestins and disease-linked variants: opportunities for targeted modulation.Semantic proximity Read

Hidden Bias: GPCR Polymorphisms and the Genomic Landscape of β-Arrestin SignalingSemantic proximity Read

Automated design and optimization of multitarget schizophrenia drug candidates by deep learningSemantic proximity Read

Structural Genomics of the Human Dopamine Receptor SystemSemantic proximity Read